SUMMIT THERAPEUTICS INC. (SMMT)
Clinical trial NCT07607301: enrollment: not set → 96 participants.
BRISTOL MYERS SQUIBB CO (BMY)
Clinical trial NCT04064060: enrollment: not set → 665 participants.
MERCK & CO., INC. (MRK)
Clinical trial NCT04896008: enrollment: not set → 173 participants.
UNITED THERAPEUTICS CORP (UTHR)
Clinical trial NCT06687746 updates: 1. status: ACTIVE_NOT_RECRUITING → COMPLETED 2. completion date: 2026-04-01 → 2026-03-03 3. primary completion date: 2026-04-01 → 2026-03-03 4. enrollment: not set → 4060 participants
ASTRAZENECA PLC (AZN)
Clinical trial NCT07290283: enrollment: not set → 176 participants.
NETO MALINDA TRADING LTD (NTML)
The company’s outstanding liabilities as of March 31, 2026, by maturity dates
ASTRAZENECA PLC (AZN)
Clinical trial NCT06455449: enrollment: not set → 240 participants.
BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT07607743: enrollment: not set → 240 participants.
ABBVIE INC. (ABBV)
Clinical trial NCT06880744 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. primary completion date: 2028-09-01 → 2027-08-01 3. enrollment: not set → 573 participants
THERAPEUTIC SOLUTIONS INTERNATIONAL, INC. (TSOI)
Clinical trial NCT07205081 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: not set → 72 participants